Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 84
Selected: 0
NCT IDTitle
NCT01909856The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy
NCT01554917A Study of Iguratimod in Patients With Active Rheumatoid Arthritis
NCT05826249Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects
NCT05528055A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors
NCT01548001Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis
NCT05254665A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors
NCT02275299Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis
NCT02652234Study of Endostar Subcutaneous Injection in NSCLC
NCT06686745Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
NCT04830644A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
NCT05718219Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors
NCT04671849An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Mutations.
NCT02805010Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
NCT01893151Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI
NCT04902885Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients
NCT07361003A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
NCT05339646A Phase I Clinical Study of SSD8432 in Healthy Adult Subjects
NCT02283476The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.
NCT05885919Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
NCT02004548Phase I Clinical Study of Metatinib Tromethamine Tablet
NCT06536036Evaluate the Effects of Food on the Pharmacokinetics of SIM0270
NCT03763123A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.
NCT05373446Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical Study
NCT01410370Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases
NCT01459081Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
NCT03577392Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer.
NCT07618260SIM0613 in Participants With Advanced Solid Tumors
NCT01368419Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
NCT03588494Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer
NCT01772732Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC
NCT04914598A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions
NCT06654791Mass Balance Clinical Trial of SIM0270
NCT05506176A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19
NCT05803135Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis
NCT05475834Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants
NCT06186414A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC
NCT04440436Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients
NCT06010693A Study of Daridorexant in Chinese Patients With Insomnia Disorder
NCT01531790A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
NCT05369676To Evaluate SSD8432/ Ritonavir in Adults With COVID-19
NCT03424928A Pilot Bioequivalence Study of Pomalidomide
NCT05665647Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Participants
NCT07175233A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis
NCT01327235Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
NCT06331559Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
NCT05373433To Evaluate SSD8432/Ritonavir in Adults With COVID-19
NCT07266493Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT02088515Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
NCT05293964Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
NCT02375022Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations